ReviewProgress in cardiovascular diseases
Implications of obesity across the heart failure continuum.
Review in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 56 citations in OpenAlex.
- Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Heart Failure Independently Predicts Higher Morbidity and Mortality Following Bariatric Surgery: Analysis of 180,544 MBSAQIP Cases.Obesity surgery · 2026Article
- Obesity Is Associated with a Lower Risk of Mortality and Readmission in Heart Failure Patients with Diabetes.Biomedicines · 2025Article
- NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients.BMC geriatrics · 2025Article
- THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARD.Transactions of the American Clinical and Climatological Association · 2025Review
- Non-Pharmacological Therapy in Heart Failure and Management of Heart Failure in Special Populations-A Review.Journal of clinical medicine · 2024Review
- Impact of Donor-Recipient BMI Ratio on Survival Outcomes of Heart Transplant Recipients: A Retrospective Analysis Study.Clinical cardiology · 2024Article
- Harmony in Chaos: Deciphering the Influence of Ischemic Cardiomyopathy and Non-Cardiac Comorbidities on Holter ECG Parameters in Chronic Heart Failure Patients: A Pilot Study.Medicina (Kaunas, Lithuania) · 2024Article
- Body mass index and survival in people with heart failure.Heart (British Cardiac Society) · 2023Article
- Association of Size Matching Using Predicted Heart Mass With Mortality in Heart Transplant Recipients With Obesity or High Pulmonary Vascular Resistance.JAMA network open · 2023Article
- Better pharmacotherapy in heart failure with reduced ejection fraction may partly explain the obesity paradox.European journal of heart failure · 2023Article
- Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.European heart journal · 2023Article
- Midterm Outcomes of Underweight Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the LAPLACE-TAVR Registry.JACC. Asia · 2023Article
- Associations of Body-Roundness Index and Sarcopenia with Cardiovascular Disease among Middle-Aged and Older Adults: Findings from CHARLS.The journal of nutrition, health & aging · 2023Article
- Weighing in on weight loss in heart failure with reduced ejection fraction.European journal of heart failure · 2023Article
- Impact of the Obesity Paradox Between Sexes on In-Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study.Journal of the American Heart Association · 2022Observational
- Is There an Obesity Paradox in Cardiogenic Shock?Journal of the American Heart Association · 2022Article
- Taking the Obesity Paradox to New Heights in Cerebral Atherosclerosis.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2022Article
- Bariatric Surgery as the One Route to Achieving Donor Heart Transplantation in a Patient with a Left-Ventricular Assist Device.Obesity facts · 2022Article
- Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF.Cardiovascular therapeutics · 2022Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The obesity paradox, which suggests a survival advantage for the obese in heart failure (HF) has sparked debate in the medical community. Studies demonstrate a survival advantage in obese patients with HF, including those with advanced HF requiring continuous inotropic support for palliation or disease modifying therapy with a left ventricular assist device (LVAD) or heart transplantation (HT). Importantly, the obesity paradox is affected by the level of cardiorespiratory fitness (CRF). It is now recommended that HF patients with body mass index ≥35 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.